Skip to main content
Premium Trial:

Request an Annual Quote

BD Buys Dynacon's Lab Systems Business

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Becton Dickinson said today that its BD Diagnostics segment has acquired Dynacon’s Lab Systems business, which offers microbiology specimen-processing technologies, for an undisclosed sum.

The purchase of the business from privately held Dynacon, which closed on March 29, gives BD Diagnostics two new products, the InocuLab system for processing microbial specimens and the Innova Preanalytical Automated Microbiology Specimen Processor, which is a higher-throughput, automated version of the InocuLab.

BD said that the Innova System accommodates the “full range of microbiology specimen containers, streak patterns, protocols, and workflows.”

Dynacon’s CEO Peter Hughes said that the Innova and the InnocuLab platforms “complement perfectly” BD’s product line in infectious disease testing.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.